These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review. Tamura K; Ohtsuka T; Ideno N; Aso T; Shindo K; Aishima S; Ohuchida K; Takahata S; Ushijima Y; Ito T; Oda Y; Mizumoto K; Tanaka M Ann Surg; 2014 Feb; 259(2):360-8. PubMed ID: 23989056 [TBL] [Abstract][Full Text] [Related]
5. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas. Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244 [TBL] [Abstract][Full Text] [Related]
6. Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis. Marchegiani G; Mino-Kenudson M; Ferrone CR; Warshaw AL; Lillemoe KD; Fernández-del Castillo C J Am Coll Surg; 2015 May; 220(5):839-44. PubMed ID: 25840549 [TBL] [Abstract][Full Text] [Related]
7. Parenchyma-sparing pancreatectomy for presumed noninvasive intraductal papillary mucinous neoplasms of the pancreas. Sauvanet A; Gaujoux S; Blanc B; Couvelard A; Dokmak S; Vullierme MP; Ruszniewski P; Belghiti J; Lévy P Ann Surg; 2014 Aug; 260(2):364-71. PubMed ID: 24646561 [TBL] [Abstract][Full Text] [Related]
8. Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-Making. Marchegiani G; Crippa S; Perri G; Rancoita PMV; Caravati A; Belfiori G; Dall'Olio T; Aleotti F; Partelli S; Bassi C; Falconi M; Salvia R Ann Surg Oncol; 2022 May; 29(5):3206-3214. PubMed ID: 35072863 [TBL] [Abstract][Full Text] [Related]
12. Predictors of long-term survival after resection of adenocarcinoma arising from intraductal papillary mucinous neoplasm and derivation of a prognostic model: An international multicenter study (ADENO-IPMN study). Lucocq J; Joseph N; Hawkyard J; Haugk B; White S; Lye J; Parkinson D; Mownah O; Menon K; Furukawa T; Hirose Y; Sasahira N; Inoue Y; Mittal A; Samra J; Sheen A; Feretis M; Balakrishnan A; Ceresa C; Davidson B; Pande R; Dasari B; Roberts K; Tanno L; Karavias D; Helliwell J; Young A; Marks K; Nunes Q; Urbonas T; Silva M; Gordon-Weeks A; Barrie J; Gomez D; van Laarhoven S; Nawara H; Doyle J; Bhogal R; Harrison E; Roalso M; Ciprani D; Aroori S; Ratnayake B; Koea J; Capurso G; Stättner S; Bellotti R; Alsaoudi T; Bhardwaj N; Rajesh S; Jeffery F; Connor S; Cameron A; Jamieson N; Gill A; Soreide K; Pandanaboyana S Surgery; 2024 Sep; 176(3):890-898. PubMed ID: 38918108 [TBL] [Abstract][Full Text] [Related]
13. Data analysis of 36 cases with intraductal papillary mucinous neoplasm of the pancreas for their clinicopathological features, diagnosis, and treatment. Yuan C; Xiu D; Tao M; Ma Z; Jiang B; Li Z; Li L; Wang L; Wang H; Zhang T Chin Med J (Engl); 2014; 127(23):4087-91. PubMed ID: 25430454 [TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium. Attiyeh MA; Fernández-Del Castillo C; Al Efishat M; Eaton AA; Gönen M; Batts R; Pergolini I; Rezaee N; Lillemoe KD; Ferrone CR; Mino-Kenudson M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Wolfgang CL; Allen PJ Ann Surg; 2018 Jan; 267(1):157-163. PubMed ID: 28079542 [TBL] [Abstract][Full Text] [Related]
15. Inferior head resection of the pancreas for intraductal papillary mucinous neoplasms. Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kobayashi S; Kojima M; Miyauchi H; Asano T J Hepatobiliary Pancreat Sci; 2010 Nov; 17(6):798-802. PubMed ID: 19727540 [TBL] [Abstract][Full Text] [Related]
16. Long-term prospective cohort study of patients undergoing pancreatectomy for intraductal papillary mucinous neoplasm of the pancreas: implications for postoperative surveillance. Kang MJ; Jang JY; Lee KB; Chang YR; Kwon W; Kim SW Ann Surg; 2014 Aug; 260(2):356-63. PubMed ID: 24378847 [TBL] [Abstract][Full Text] [Related]
17. Optimal surveillance of intraductal papillary mucinous neoplasms of the pancreas focusing on remnant pancreas recurrence after surgical resection. Fuji T; Umeda Y; Takagi K; Yoshida R; Yoshida K; Yasui K; Matsumoto K; Kato H; Yagi T; Fujiwara T BMC Cancer; 2022 May; 22(1):588. PubMed ID: 35643422 [TBL] [Abstract][Full Text] [Related]
18. Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis. Crippa S; Bassi C; Salvia R; Malleo G; Marchegiani G; Rebours V; Levy P; Partelli S; Suleiman SL; Banks PA; Ahmed N; Chari ST; Fernández-Del Castillo C; Falconi M Gut; 2017 Mar; 66(3):495-506. PubMed ID: 26743012 [TBL] [Abstract][Full Text] [Related]